Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06596837Not ApplicableCompleted

Virtual Reality and Coping with Procedural Pain in Burn Patients

Role: collaborator

NCT05323916Not ApplicableRecruiting

Comprehensive Intensive Stroke Rehabilitation

Role: collaborator

NCT04796558Active Not Recruiting

Validation of Arterio Venous Access Stage (AVAS) Classification

Role: lead

NCT06276296Unknown

Heart Rate Variability After Ablation

Role: collaborator

NCT04663555Phase 4Completed

Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19

Role: collaborator

NCT05232539Not ApplicableUnknown

Efficiency of Intraoperative Optical Coherence Tomography (iOCT)

Role: collaborator

All 6 trials loaded